A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RA

NCT03147248 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
407
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Celltrion